HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity
Article in International Immunopharmacology (July 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases
Article in Metabolism (January 2020)
The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.
Article in Cardiovascular Endocrinology & Metabolism (February 2019)